EVP and General Manager, Diabetes Business Unit @ (January 2009 - October 2010)
Executive Vice President @ (June 2007 - January 2009)
VP Marketing, Europe @ (January 2005 - June 2007)
Director of Marketing @ Bayer Diagnostics (January 2004 - January 2005)
Sales and Marketing @ Bayer Diagnostics (January 1994 - January 2004)
Sales Rep @ (January 1992 - January 1994)
Michael Iskra Education
Columbia Business School
General Management Leadership Program
2010-2010
University of Notre Dame - Mendoza College of Business
Executive Management Program
2002-2002
University of Delaware
BA (International Relations)
1987-1992
Michael Iskra Skills
Strategy
Sales Management
Healthcare
Medical Devices
Managed Care
Marketing
P&L Management
Operations Management
Business Development
Leadership
Product Launch
Organizational Leadership
Sales
Cross-functional Team Leadership
Management
Workshop Facilitation
Strategic Planning
Business Process Improvement
Strategy Development
Diabetes
Sales Operations
Business Strategy
Launch Of New Products
Hospitals
Pharmaceutical Industry
Business Planning
Process Improvement
Start-ups
Team Building
Capital Equipment
New Business Development
Mergers & Acquisitions
General management
Large Group Facilitation
Acquisition Integration
Business Transformation
Go-to-Market Strategy
Initial Public Offerings (IPO)
International Business
Public Speaking
Start Ups
Microsoft Excel
Cross Functional Team Leadership
JavaScript
Mergers and Acquisitions
Michael Iskra Summary
Michael Iskra, based in United States, is currently a Chief Executive Officer at Cleveland Diagnostics. Michael Iskra brings experience from previous roles at Ascentry, Spark CAO, Amplity and QuidelOrtho. Michael Iskra holds a 2010 - 2010 General Management Leadership Program @ Columbia Business School. With a robust skill set that includes Strategy, Sales Management, Healthcare, Medical Devices, Managed Care and more. Michael Iskra has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michael Iskra?
Find contact details for 700 million professionals.